Page results
-
Media statement UCLH chief executive David Probert said: “Many congratulations to Carrie and Boris Johnson on the birth of their baby daughter Romy Iris Charlotte Johnson. We wish…
-
Omnipod 5 users will get a notification on their Omnipod 5 Controller to install a software update (version 2.0).
-
We are excited to share news that Genomics England has launched an initiative that will directly benefit patients from underrepresented populations such as those living with sickle cell disorder.
-
Charity Myeloma UK awards UCLH haematology team their Clinical Service Excellence Programme (CSEP) award in recognition of their outstanding care and unflagging dedication to patients living myeloma, an incurable blood cancer.
-
Researchers at the NIHR UCLH Clinical Research Facility are the first in the world to start a new first-in-human trial investigating a novel treatment, called NVG-111, in patients with Non-Hodgkin lymphoma (NHL) subtypes.
-
Contact the UCLH Media and Communications team. Read the UCLH magazine.
-
The research aims to improve patient care and safety in acute and critical care, surgical care and perioperative care settings.
-
The team behind the Royal National ENT and Eastman Dental Hospitals won the Estates Initiative of the Year at the HSJ Value Awards 2020.
-
Prime Minister Boris Johnson came to the UCLH vaccination centre based at The Francis Crick Institute to receive his second COVID-19 vaccination.
File results
-
FOI/2024/0607 - Starvation ketoacidosis patients/ treatment
-
FOI/2024/0605 - Finance software system/ installation and expiry of software
-
FOI/2024/0597 - Urothelial cancer treatments
-
FOI/2024/0595 - Capital estate activity for 2020-2024
-
FOI/2024/0594 - Implementation of Federated Data Platform (FDP) and procurement of data platforms
-
FOI/2024/0589 - SACT Cancer report/ Drug Patient Level Contract Monitoring (DrPLCM) report
-
FOI/2024/0458 - Infected blood products, patient numbers 2019/20-2023/24
-
FOI/2024/0446 - Skin cancer treatment times 2019/20-2023/24
-
FOI/2022/0780 - Hereditary Angioedema (HAE) service
-
FOI/2024/0577 - Diffuse Large B Cell Lymphoma treatments